Susquehanna International Group, LLP Sellas Life Sciences Group, Inc. Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
A detailed history of Susquehanna International Group, LLP transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 688,696 shares of SLS stock, worth $1.06 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
688,696
Previous 21,000
3179.5%
Holding current value
$1.06 Million
Previous $21,000
3438.1%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding SLS
# of Institutions
52Shares Held
14.5MCall Options Held
538KPut Options Held
26.3K-
Anson Funds Management LP Dallas, TX7.58MShares$11.7 Million1.95% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.84MShares$4.37 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA820KShares$1.26 Million0.0% of portfolio
-
Black Rock Inc. New York, NY430KShares$662,7660.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il350KShares$538,2370.0% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $31.6M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...